PM321. DNA Methylation Signature Associated with Abstinence in Alcoholics Treated with Acamprosate

por Hlady, R., Robertson, K., Biernacka, J. M., Jenkins, G., Karpyak, V. M.
Publicado 2016

Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects

por Nam, H W, Karpyak, V M, Hinton, D J, Geske, J R, Ho, A M C, Prieto, M L, Biernacka, J M, Frye, M A, Weinshilboum, R M, Choi, D-S
Publicado 2015

Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate

por Karpyak, V M, Biernacka, J M, Geske, J R, Jenkins, G D, Cunningham, J M, Rüegg, J, Kononenko, O, Leontovich, A A, Abulseoud, O A, Hall-Flavin, D K, Loukianova, L L, Schneekloth, T D, Skime, M K, Frank, J, Nöthen, M M, Rietschel, M, Kiefer, F, Mann, K F, Weinshilboum, R M, Frye, M A, Choi, D S
Publicado 2014